Home / Health / India's HPV Vaccine: Facts vs. Fears
India's HPV Vaccine: Facts vs. Fears
16 Sep
Summary
- Myths about fertility and safety cause vaccine hesitancy.
- Vaccine prevents new HPV infections before exposure.
- Regular screening remains crucial post-vaccination.
Many parents in India express anxiety surrounding the HPV vaccine, despite its free availability to millions of adolescent girls. Concerns about fertility, safety, and potential links to early sexual activity are leading to parental hesitation. Health experts emphasize that the human papillomavirus (HPV) is a common infection, and high-risk strains can lead to cervical cancer.
The timing of the HPV vaccine is medical, aimed at preventing new infections before exposure, not influencing behavior. Extensive global safety monitoring by organizations like the WHO has found no evidence linking the vaccine to infertility or premature ovarian failure. It is recommended for girls aged 9-14.
While the vaccine dramatically lowers the risk of infection from specific HPV strains, it does not eliminate the possibility of cervical cancer entirely. Therefore, regular screening remains a critical component of healthcare for women. India's approach integrates vaccination with screening, early diagnosis, and timely treatment.
Concerns about the vaccine being experimental are unfounded, as HPV vaccines have a long international safety record with over 500 million doses administered globally. India's national program utilizes the WHO-prequalified Gardasil-4 vaccine, ensuring its established safety profile for adolescents.
